Tokyo - Delayed Quote JPY

Immuno-Biological Laboratories Co., Ltd. (4570.T)

450.00
-2.00
(-0.44%)
At close: 3:30:00 PM GMT+9
Currency in JPY All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
816,701
816,701
794,621
647,576
602,749
Cost of Revenue
299,408
299,408
267,908
270,878
255,894
Gross Profit
517,293
517,293
526,712
376,697
346,855
Operating Expense
412,990
412,990
468,333
498,912
587,833
Operating Income
104,303
104,303
58,379
-122,215
-240,978
Net Non Operating Interest Income Expense
-1,037
-1,037
283
-154
-598
Pretax Income
124,644
124,644
-280,611
-250,142
-310,630
Tax Provision
-62,050
-62,050
9,119
8,625
8,197
Net Income Common Stockholders
186,694
186,694
-289,731
-258,767
-318,827
Diluted NI Available to Com Stockholders
186,694
186,694
-289,731
-258,767
-318,827
Basic EPS
20.05
--
-31.10
-27.78
-34.23
Diluted EPS
20.05
--
-31.10
-27.78
-34.23
Basic Average Shares
9,313.46
--
9,313.46
9,313.46
9,313.46
Diluted Average Shares
9,313.46
--
9,313.46
9,313.46
9,313.46
Total Operating Income as Reported
104,299
104,299
58,373
-122,219
-240,984
Total Expenses
712,398
712,398
736,241
769,790
843,727
Net Income from Continuing & Discontinued Operation
186,694
186,694
-289,731
-258,767
-318,827
Normalized Income
181,949.30
181,949.30
-187,598.52
-271,372.18
-319,540.23
Interest Income
93
93
1,356
487
151
Interest Expense
1,130
1,130
1,073
641
749
Net Interest Income
-1,037
-1,037
283
-154
-598
EBIT
125,774
125,774
-279,538
-249,501
-309,881
EBITDA
128,107
128,107
-279,538
-249,501
-309,881
Reconciled Cost of Revenue
299,408
299,408
267,908
270,878
255,894
Reconciled Depreciation
2,333
2,333
--
--
--
Net Income from Continuing Operation Net Minority Interest
186,694
186,694
-289,731
-258,767
-318,827
Total Unusual Items Excluding Goodwill
6,178
6,178
-132,985
16,413
1,028
Total Unusual Items
6,178
6,178
-132,985
16,413
1,028
Normalized EBITDA
121,929
121,929
-146,553
-265,914
-310,909
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
1,433.30
1,433.30
-30,852.52
3,807.82
314.77
3/31/2021 - 8/15/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

8158.HK China Regenerative Medicine International Limited
0.425
0.00%
 
6978.HK Immunotech Biopharm Ltd
3.990
-4.77%
 
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
298.600
-0.47%
 
NAYA INVO Fertility, Inc.
1.9950
+10.83%
 
SVRA Savara Inc.
3.2800
+1.86%
 
OSTX OS Therapies Incorporated
1.5588
+2.55%
 
MRNA Moderna, Inc.
26.91
+4.55%